Trial
NCT03325322
Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Chronic Kidney Diseases
Intervention
Fisetin
Why stopped
Due to lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-28